Your session is about to expire
← Back to Search
Multimodal TENS Unit for Opioid Use Disorder
Study Summary
This trial is looking at whether the use of opioids to treat chronic low back pain is effective, and if so, whether a particular type of opioid, DuoTherm, is more effective than a placebo.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Could I potentially qualify for this research endeavor?
"This medical trial is looking for 100 individuals with chronic lower back pain, ranging from 18 to 90 in age. To be eligible, applicants must have been diagnosed by a healthcare professional, report moderate or higher levels of discomfort on the NRS scale, be willing to share information about their prescribed medication (or someone else's if applicable), had symptoms lasting more than three months and are able understand the study's risks and benefits before signing an informed consent form."
Are any geriatric patients eligible to participate in this investigation?
"The lower bound for this medical trial is 18 years old and the upper limit is 90."
What is the total count of participants involved in this experiment?
"Affirmative. According to the information hosted by clinicaltrials.gov, this research is actively seeking participants; it was initially posted on June 23rd 2022 and updated most recently in October 19th 2022. The experiment necessitates 100 individuals from 3 separate sites for completion."
Does this trial still have vacancies for volunteers?
"Examining the data on clinicaltrials.gov, this scientific research is recruiting participants at present time. Initially posted in June of 2022, it has seen its most recent edit take place in October of the same year."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger